Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

par pharmaceutical inc. - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast 10 mg

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

astrazeneca pharmaceuticals lp - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast 10 mg

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

state of florida doh central pharmacy - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast 20 mg - accolate is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. accolate is contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients.

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

camber pharmaceuticals, inc. - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. zafirlukast is contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients. zafirlukast is contraindicated in patients with hepatic impairment including hepatic cirrhosis.

Malta - anglų - Medicines Authority

astrazeneca uk limited 600, capability green, luton lu1 3lu, united kingdom - zafirlukast - tablet - zafirlukast 20 mg - drugs for obstructive airway diseases

Kanada - anglų - Health Canada

astrazeneca canada inc - zafirlukast - tablet - 20mg - zafirlukast 20mg - leukotriene modifiers

Didžioji Britanija - anglų - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - zafirlukast - oral tablet - 20mg

Didžioji Britanija - anglų - MHRA (Medicines & Healthcare Products Regulatory Agency)

astrazeneca uk ltd - zafirlukast - oral tablet - 20mg

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

par pharmaceutical, inc. - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast 10 mg - accolate is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. accolate is contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients. accolate is contraindicated in patients with hepatic impairment including hepatic cirrhosis.

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

bryant ranch prepack - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. zafirlukast is contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients. zafirlukast is contraindicated in patients with hepatic impairment including hepatic cirrhosis.